Potential role of vitamin D in patients with diabetes, dyslipidaemia, and COVID-19.
World J Crit Care Med
; 11(2): 112-114, 2022 Mar 09.
Article
in English
| MEDLINE | ID: covidwho-1791994
ABSTRACT
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 has become a worldwide public health crisis. Studies have demonstrated that diabetes and dyslipidaemia are common comorbidities and could be high-risk factors for severe COVID-19. Vitamin D, a group of fat-soluble compounds responsible for intestinal absorption of calcium, magnesium, and phosphate, has been widely used as a dietary supplement for the prevention and treatment of numerous diseases, including infectious and non-infectious diseases, due to its high cost-effectiveness; safety; tolerability; and anti-thrombotic, anti-inflammatory, antiviral, and immunomodulatory properties. In this letter to the editor, we mainly discuss the potential role of vitamin D in patients with diabetes, dyslipidaemia, and COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Topics:
Traditional medicine
Language:
English
Journal:
World J Crit Care Med
Year:
2022
Document Type:
Article
Affiliation country:
Wjccm.v11.i2.112
Similar
MEDLINE
...
LILACS
LIS